NCT07893197
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07893197
Title Ceritinib Treatment for Recurrent Meningiomas (CURE-M)
Acronym CURE-M
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kevin Petrecca
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.